B2M and myeloid sarcoma: Indeed, this model of CD8+ T cell–driven injury is strongly supported by prior reports of clonally expanded CD8+ T cells in MS lesions as well as the evidence we provide of elevated levels of MHC class I and β2M in neurons and axons of MS patients.